Overview

Depocyt® With Sorafenib in Neoplastic Meningitis

Status:
Terminated
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the tolerability and side effects of oral sorafenib in combination with intrathecal DepoCyt.
Phase:
N/A
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborator:
Bayer
Treatments:
Cytarabine
Niacinamide
Sorafenib